NCT02152293View on ClinicalTrials.gov

Impact of Chloroprocaine (CLOROTEKAL®) on Eligibility for Discharge From Hospital After Outpatient Surgery

CompletedOBSERVATIONAL

Enrollment

620

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions

Spinal AnesthesiaOutpatient Surgery

Trial Locations (1)

Unknown

Nordic Pharma, Paris

Sponsors

Lead Sponsor

Nordic Pharma SAS

All Listed Sponsors

lead

Nordic Pharma SAS

INDUSTRY

NCT02152293 - Impact of Chloroprocaine (CLOROTEKAL®) on Eligibility for Discharge From Hospital After Outpatient Surgery | Biotech Hunter | Biotech Hunter